Literature DB >> 208961

A virus-producing cell line developed by transformation of human parapharyngeal cells with SV40.

K A Rafferty, R L Ruben, S K Young.   

Abstract

Normal cultures of epithelial appearance were initiated by trypsinization of a surgically resected, histologically normal branchial cyst. Cellular morphology was consistent with derivation from the stratified squamous epithelium of the cyst or from vascular endothelium, although electron micrographs of the cultured cells failed to show any junctional complexes. Infection with SV40 produced transformants which were also epithelioid in appearance. These grew vigorously for 22 to 50 population doublings (about 23 to 32 subcultures, depending upon regimen) and then became quiescent. During this evolution, virus was detectable at all stages by both direct isolation (cell extracts) and cocultivation with permissive cells. In two sublines in which selection for rapidly growing cell types occureed, virus was detected only by cocultivation. The work confirms that of others in the finding that normal human epithelial cells are susceptible to transformation by oncogenic viruses, but are apparently less responsive than are fibroblasts to such transforming agents. It also suggests that subcultivation techniques that maintain the populations of transformed cells at low density tend to select against cell strains that are continous producers of infectious virus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 208961     DOI: 10.1007/bf02618227

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  19 in total

1.  BIOLOGIC CHARACTERISTICS OF A CONTINUOUS KIDNEY CELL LINE DERIVED FROM THE AFRICAN GREEN MONKEY.

Authors:  H E HOPPS; B C BERNHEIM; A NISALAK; J H TJIO; J E SMADEL
Journal:  J Immunol       Date:  1963-09       Impact factor: 5.422

Review 2.  CHROMOSOME CYTOLOGY.

Authors:  P S MOORHEAD; P C NOWELL
Journal:  Methods Med Res       Date:  1964

3.  The production of infective virus by SV40-transformed human renal cells.

Authors:  J van der Noordaa; W Pauw
Journal:  J Gen Virol       Date:  1973-02       Impact factor: 3.891

4.  SV40 transformation of human amnion cells under different culture conditions.

Authors:  J Fogh; E V Gaffney; J D Loveless
Journal:  Proc Soc Exp Biol Med       Date:  1970-05

5.  Established lines of SV40-transformed human amnion cells.

Authors:  E V Gaffney; J Fogh; L Ramos; J D Loveless; H Fogh; A M Dowling
Journal:  Cancer Res       Date:  1970-06       Impact factor: 12.701

6.  Activation of production of infectious tumor virus SV40 in heterokaryon cultures.

Authors:  H Koprowski; F C Jensen; Z Steplewski
Journal:  Proc Natl Acad Sci U S A       Date:  1967-07       Impact factor: 11.205

Review 7.  Genetic markers as tracers in cell culture.

Authors:  S M Gartler
Journal:  Natl Cancer Inst Monogr       Date:  1967-09

8.  Observations on the growth phases of human amnion cell cultures.

Authors:  R S Chang
Journal:  J Natl Cancer Inst       Date:  1968-03       Impact factor: 13.506

9.  In vitro viral transformation of human prostatic carcinoma.

Authors:  R E Jones; E J Sanford; T J Rohner; F Rapp
Journal:  J Urol       Date:  1976-01       Impact factor: 7.450

10.  Proposed usage of animal tissue culture terms.

Authors:  S Fedoroff
Journal:  J Natl Cancer Inst       Date:  1967-04       Impact factor: 13.506

View more
  4 in total

1.  Chromosome analyses and anchorage-independent growth of SV40-induced morphologically transformed epithelial cells from amniotic fluids.

Authors:  K H Walen
Journal:  In Vitro       Date:  1981-06

Review 2.  Human cell transformation by simian virus 40--a review.

Authors:  G H Sack
Journal:  In Vitro       Date:  1981-01

Review 3.  Papovaviral persistent infections.

Authors:  L C Norkin
Journal:  Microbiol Rev       Date:  1982-12

4.  Induction of tumorigenesis and chromosomal abnormalities in human amniocytes infected with simian virus 40 and Kirsten sarcoma virus.

Authors:  K H Walen; P Arnstein
Journal:  In Vitro Cell Dev Biol       Date:  1986-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.